News coverage about PetMed Express (NASDAQ:PETS) has been trending somewhat positive on Saturday, Accern reports. The research group identifies positive and negative media coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. PetMed Express earned a media sentiment score of 0.22 on Accern’s scale. Accern also assigned news stories about the company an impact score of 45.8760516610662 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.
These are some of the news headlines that may have impacted Accern Sentiment Analysis’s scoring:
PetMed Express (NASDAQ PETS) traded up $0.53 on Friday, reaching $37.29. 428,100 shares of the company’s stock were exchanged, compared to its average volume of 662,861. The stock has a market cap of $757.41, a P/E ratio of 24.67, a price-to-earnings-growth ratio of 2.22 and a beta of 1.09. PetMed Express has a 1 year low of $19.21 and a 1 year high of $50.90.
PetMed Express (NASDAQ:PETS) last posted its quarterly earnings data on Monday, October 23rd. The company reported $0.43 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.30 by $0.13. The firm had revenue of $66.70 million for the quarter, compared to the consensus estimate of $63.41 million. PetMed Express had a net margin of 11.58% and a return on equity of 31.46%. The business’s revenue for the quarter was up 9.7% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.24 EPS. analysts anticipate that PetMed Express will post 1.66 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Friday, November 17th. Investors of record on Monday, November 6th will be issued a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.15%. The ex-dividend date is Friday, November 3rd. PetMed Express’s dividend payout ratio (DPR) is currently 53.69%.
Several analysts have recently weighed in on PETS shares. Zacks Investment Research lowered shares of PetMed Express from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 25th. ValuEngine upgraded shares of PetMed Express from a “hold” rating to a “buy” rating in a research note on Friday, September 1st. Sidoti upgraded shares of PetMed Express from a “neutral” rating to a “buy” rating and set a $47.00 price objective for the company in a research note on Thursday, August 24th. BidaskClub lowered shares of PetMed Express from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, August 22nd. Finally, Noble Financial restated a “hold” rating on shares of PetMed Express in a research note on Friday, October 27th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and three have assigned a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus target price of $42.00.
COPYRIGHT VIOLATION NOTICE: This news story was first published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this news story on another publication, it was copied illegally and reposted in violation of U.S. & international copyright legislation. The original version of this news story can be viewed at https://www.dispatchtribunal.com/2017/11/11/petmed-express-pets-earning-somewhat-favorable-news-coverage-accern-reports.html.
In related news, Director Ronald J. Korn sold 1,000 shares of the business’s stock in a transaction dated Friday, October 27th. The shares were sold at an average price of $35.57, for a total value of $35,570.00. Following the transaction, the director now directly owns 73,833 shares of the company’s stock, valued at approximately $2,626,239.81. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 4.00% of the stock is currently owned by insiders.
About PetMed Express
PetMed Express, Inc (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.
Receive News & Ratings for PetMed Express Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express Inc. and related companies with MarketBeat.com's FREE daily email newsletter.